Cardinal Health, Inc. (NYSE:CAH) Holdings Lowered by Gulf International Bank UK Ltd

Gulf International Bank UK Ltd trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 3.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 57,840 shares of the company’s stock after selling 1,939 shares during the period. Gulf International Bank UK Ltd’s holdings in Cardinal Health were worth $2,860,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of CAH. Maverick Capital Ltd. acquired a new position in Cardinal Health during the second quarter valued at $35,000. Eubel Brady & Suttman Asset Management Inc. acquired a new position in Cardinal Health during the second quarter valued at $55,000. Signaturefd LLC raised its position in Cardinal Health by 23.2% during the third quarter. Signaturefd LLC now owns 1,244 shares of the company’s stock valued at $62,000 after buying an additional 234 shares during the period. Berman Capital Advisors LLC raised its position in Cardinal Health by 96.0% during the third quarter. Berman Capital Advisors LLC now owns 1,554 shares of the company’s stock valued at $76,000 after buying an additional 761 shares during the period. Finally, Fieldpoint Private Securities LLC raised its position in Cardinal Health by 18.8% during the second quarter. Fieldpoint Private Securities LLC now owns 1,690 shares of the company’s stock valued at $86,000 after buying an additional 268 shares during the period. 84.29% of the stock is currently owned by hedge funds and other institutional investors.

In other Cardinal Health news, insider Ola M. Snow sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 18th. The stock was sold at an average price of $49.17, for a total value of $491,700.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.41% of the stock is currently owned by company insiders.

CAH has been the topic of several recent analyst reports. Barclays dropped their price target on Cardinal Health from $65.00 to $63.00 and set an “overweight” rating on the stock in a research report on Tuesday. Deutsche Bank Aktiengesellschaft upped their target price on Cardinal Health from $51.00 to $59.00 and gave the stock a “hold” rating in a research report on Friday, November 12th. Credit Suisse Group decreased their price target on Cardinal Health from $53.00 to $50.00 and set a “neutral” rating for the company in a research note on Monday, November 15th. Mizuho decreased their price target on Cardinal Health from $56.00 to $53.00 and set a “neutral” rating for the company in a research note on Wednesday, November 10th. Finally, Morgan Stanley decreased their price target on Cardinal Health from $64.00 to $54.00 and set an “equal weight” rating for the company in a research note on Friday, December 17th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $55.00.

Shares of NYSE:CAH opened at $53.09 on Friday. The business has a 50 day moving average price of $49.92 and a 200 day moving average price of $51.82. Cardinal Health, Inc. has a twelve month low of $45.85 and a twelve month high of $62.96. The company has a market cap of $14.96 billion, a price-to-earnings ratio of 13.72, a PEG ratio of 2.02 and a beta of 0.98. The company has a quick ratio of 0.57, a current ratio of 1.12 and a debt-to-equity ratio of 3.83.

Cardinal Health (NYSE:CAH) last announced its earnings results on Monday, November 8th. The company reported $1.29 earnings per share for the quarter, missing the consensus estimate of $1.32 by ($0.03). Cardinal Health had a net margin of 0.68% and a return on equity of 89.90%. The business had revenue of $43.97 billion for the quarter, compared to the consensus estimate of $41.83 billion. During the same quarter in the previous year, the company earned $1.51 EPS. Cardinal Health’s revenue for the quarter was up 12.6% compared to the same quarter last year. Analysts anticipate that Cardinal Health, Inc. will post 5.6 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, January 15th. Shareholders of record on Monday, January 3rd will be given a $0.4908 dividend. The ex-dividend date of this dividend is Friday, December 31st. This represents a $1.96 dividend on an annualized basis and a dividend yield of 3.70%. Cardinal Health’s dividend payout ratio is currently 50.65%.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency.

Recommended Story: Why do companies issue convertible shares?

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.